Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable ...

A revolutionary new pill designed to extend the lifespan of dogs has received key regulatory approval from the U.S. Food and ...

In this opinion piece, Austin Therrell, executive director of the Association of American Feed Control Officials, argues that state regulators have a timely solution for addressing the need to reform ...

FDA could allow the drug into the market, as soon as next year, once Loyalhits certain safety and manufacturing milestones.

As Artificial Intelligence continues to dominate headlines and industries, the Cornell University College of Veterinary Medicine (CVM) remains a ...

First-ever positive profit, entering a new era of growth and global innovation SAN FRANSISCO and SUZHOU, China, March 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: ...

Exelixis, Inc announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older with ...

First-ever positive profit, entering a new era of growth and global innovation ...

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers ...